These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

315 related articles for article (PubMed ID: 22263709)

  • 21. Structural and organizational factors shaping access to medication treatment for opioid use disorder in community supervision.
    Kennedy-Hendricks A; Bandara S; Merritt S; Barry CL; Saloner B
    Drug Alcohol Depend; 2021 Sep; 226():108881. PubMed ID: 34218008
    [TBL] [Abstract][Full Text] [Related]  

  • 22. COVID-19 and treating incarcerated populations for opioid use disorder.
    Donelan CJ; Hayes E; Potee RA; Schwartz L; Evans EA
    J Subst Abuse Treat; 2021 May; 124():108216. PubMed ID: 33288348
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Understanding the importance of organizational and system variables on addiction treatment services within criminal justice settings.
    McCarty D; Chandler RK
    Drug Alcohol Depend; 2009 Aug; 103 Suppl 1():S91-3. PubMed ID: 19356862
    [TBL] [Abstract][Full Text] [Related]  

  • 24. An overview on medication-assisted treatment (MAT) for opioid dependence.
    Maiti T; Das S; Ramasamy A; Stanley Xavier A; Kumar Behera S; Selvarajan S
    J Opioid Manag; 2020; 16(2):141-149. PubMed ID: 32329889
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Patients' Beliefs About Medications are Associated with Stated Preference for Methadone, Buprenorphine, Naltrexone, or no Medication-Assisted Therapy Following Inpatient Opioid Detoxification.
    Uebelacker LA; Bailey G; Herman D; Anderson B; Stein M
    J Subst Abuse Treat; 2016 Jul; 66():48-53. PubMed ID: 27211996
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A cluster randomized trial of an organizational linkage intervention for offenders with substance use disorders: study protocol.
    Friedmann PD; Ducharme LJ; Welsh W; Frisman L; Knight K; Kinlock T; Mitchell SG; Hall E; Urbine T; Gordon M; Abdel-Salam S; O'Connell D; Albizu-Garcia C; Knudsen H; Duval J; Fenster J;
    Health Justice; 2013 Dec; 1(6):. PubMed ID: 25309847
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pharmacological treatment of opioid use disorder in pregnancy.
    Rodriguez CE; Klie KA
    Semin Perinatol; 2019 Apr; 43(3):141-148. PubMed ID: 30755340
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Opioid use disorder incidence and treatment among incarcerated pregnant women in the United States: results from a national surveillance study.
    Sufrin C; Sutherland L; Beal L; Terplan M; Latkin C; Clarke JG
    Addiction; 2020 Nov; 115(11):2057-2065. PubMed ID: 32141128
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Medication-Assisted Treatment for Alcohol-Dependent Adults With Serious Mental Illness and Criminal Justice Involvement: Effects on Treatment Utilization and Outcomes.
    Robertson AG; Easter MM; Lin H; Frisman LK; Swanson JW; Swartz MS
    Am J Psychiatry; 2018 Jul; 175(7):665-673. PubMed ID: 29961358
    [TBL] [Abstract][Full Text] [Related]  

  • 30. An ethical analysis of medication treatment for opioid use disorder (MOUD) for persons who are incarcerated.
    Brezel ER; Powell T; Fox AD
    Subst Abus; 2020; 41(2):150-154. PubMed ID: 31800376
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Extended-release naltrexone opioid treatment at jail reentry (XOR).
    McDonald RD; Tofighi B; Laska E; Goldfeld K; Bonilla W; Flannery M; Santana-Correa N; Johnson CW; Leibowitz N; Rotrosen J; Gourevitch MN; Lee JD
    Contemp Clin Trials; 2016 Jul; 49():57-64. PubMed ID: 27178765
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Community correctional agents' views of medication-assisted treatment: Examining their influence on treatment referrals and community supervision practices.
    Mitchell SG; Willet J; Monico LB; James A; Rudes DS; Viglione J; Schwartz RP; Gordon MS; Friedmann PD
    Subst Abus; 2016; 37(1):127-33. PubMed ID: 26860334
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of an organizational linkage intervention on staff perceptions of medication-assisted treatment and referral intentions in community corrections.
    Friedmann PD; Wilson D; Knudsen HK; Ducharme LJ; Welsh WN; Frisman L; Knight K; Lin HJ; James A; Albizu-Garcia CE; Pankow J; Hall EA; Urbine TF; Abdel-Salam S; Duvall JL; Vocci FJ
    J Subst Abuse Treat; 2015 Mar; 50():50-8. PubMed ID: 25456091
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Beliefs about medications for opioid use disorder among Florida criminal problem-solving court & dependency court staff.
    Andraka-Christou B; Atkins D
    Am J Drug Alcohol Abuse; 2020 Nov; 46(6):749-760. PubMed ID: 32969757
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Perceptions and experiences toward extended-release buprenorphine among persons leaving jail with opioid use disorders before and during COVID-19: an in-depth qualitative study.
    Cheng A; Badolato R; Segoshi A; McDonald R; Malone M; Vasudevan K; Badiei B; Sugarman A; Macdonald R; Mangat J; Giftos J; Lee JD; Tofighi B
    Addict Sci Clin Pract; 2022 Jan; 17(1):4. PubMed ID: 35093164
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Acceptability and efficacy of naltrexone for criminal justice-involved individuals with opioid use disorder: a systematic review and meta-analysis.
    Bahji A; Carlone D; Altomare J
    Addiction; 2020 Aug; 115(8):1413-1425. PubMed ID: 31863669
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Associations among state and local organizational contexts: Use of evidence-based practices in the criminal justice system.
    Henderson CE; Young DW; Farrell J; Taxman FS
    Drug Alcohol Depend; 2009 Aug; 103 Suppl 1(Suppl 1):S23-32. PubMed ID: 19174321
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Medications for opioid use disorder among pregnant women referred by criminal justice agencies before and after Medicaid expansion: A retrospective study of admissions to treatment centers in the United States.
    Winkelman TNA; Ford BR; Shlafer RJ; McWilliams A; Admon LK; Patrick SW
    PLoS Med; 2020 May; 17(5):e1003119. PubMed ID: 32421717
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Medication assisted treatment discontinuation in pregnant and postpartum women with opioid use disorder.
    Wilder C; Lewis D; Winhusen T
    Drug Alcohol Depend; 2015 Apr; 149():225-31. PubMed ID: 25735465
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Results of a pilot randomized controlled trial of buprenorphine for opioid dependent women in the criminal justice system.
    Cropsey KL; Lane PS; Hale GJ; Jackson DO; Clark CB; Ingersoll KS; Islam MA; Stitzer ML
    Drug Alcohol Depend; 2011 Dec; 119(3):172-8. PubMed ID: 21782352
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.